Targeting Insulin Receptor with a Novel Internalizing Aptamer.
Targeting Insulin Receptor with a Novel Internalizing Aptamer.
复制标题
DOI:
10.1038/mtna.2016.73
复制
发表时间:
2016-09-20
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Nucleic acid-based aptamers are emerging as therapeutic antagonists of disease-associated proteins such as receptor tyrosine kinases. They are selected by an in vitro combinatorial chemistry approach, named Systematic Evolution of Ligands by Exponential enrichment (SELEX), and thanks to their small size and unique chemical characteristics, they possess several advantages over antibodies as diagnostics and therapeutics. In addition, aptamers that rapidly internalize into target cells hold as well great potential for their in vivo use as delivery tools of secondary therapeutic agents. Here, we describe a nuclease resistant RNA aptamer, named GL56, which specifically recognizes the insulin receptor (IR). Isolated by a cell-based SELEX method that allows enrichment for internalizing aptamers, GL56 rapidly internalizes into target cells and is able to discriminate IR from the highly homologous insulin-like growth factor receptor 1. Notably, when applied to IR expressing cancer cells, the aptamer inhibits IR dependent signaling. Given the growing interest in the insulin receptor as target for cancer treatment, GL56 reveals a novel molecule with great translational potential as inhibitor and delivery tool for IR-dependent cancers.
登录
查看更多内容
影响因子:
5.2
作者:
Malaguarnera R;Belfiore A
通讯作者:
Belfiore A
DOI:
10.1038/mtm.2016.14
发表时间:
2016
期刊:
Molecular therapy. Methods & clinical development
影响因子:
--
作者:
Maier KE;Levy M
通讯作者:
Levy M
影响因子:
3.9
作者:
Sachdev, D;Yee, D
通讯作者:
Yee, D
影响因子:
3.1
作者:
Aljada, Ahmad;Saleh, Ayman M.;Ahmed, Altayeb Abdalla
通讯作者:
Ahmed, Altayeb Abdalla
DOI:
10.1007/978-1-4939-3197-2_3
发表时间:
2016-01-01
期刊:
NUCLEIC ACID APTAMERS
影响因子:
--
作者:
Catuogno, Silvia;Esposito, Carla Lucia;de Franciscis, Vittorio
通讯作者:
de Franciscis, Vittorio